Vet PBM Growth Avant Wellness has launched the LZ30 ProZ-Vet in the UK and showcased at the London Vet Show, signaling growing demand for portable, affordable photobiomodulation lasers in veterinary practice. Sales opportunities include targeting small to mid size veterinary clinics and equine and small animal centers, emphasizing pocket sized form, fast treatment times, and ease of use. Consider offering comprehensive training, warranty, and after sales support, plus partnerships with UK distributors and veterinary associations to accelerate adoption.

UK Expansion Opportunity The UK launch and active presence at London Vet Show indicate readiness to scale internationally. Sales actions include establishing a local distribution network, service centers, and regulatory support; tailoring pricing and payment terms for European buyers; using marketing programs to reach EU clinics; initiating pilot programs with key veterinarians to demonstrate ROI.

Direct to Clinic The company's technology stack supports online sales, suggesting potential to expand direct to clinics globally. Opportunities include offering bundles with accessories and service plans, providing financing or subscription options, and optimizing digital marketing for veterinary PBM terms. Consider cross selling with related medical equipment kits to nearby clinics.

Compact Laser Value The LZ30 is described as the smallest, most powerful and easy to use class 3B laser, offering a compelling proposition for clinics with limited space or mobile practice. Sales angles include rapid PBM sessions, improved patient throughput, and lower training barriers. Target small animal clinics, emergency centers, mobile veterinarians, and residency programs.

Channel Partnerships There are opportunities to form strategic relationships with veterinary distributors, pet retailers, veterinary schools, and telemedicine platforms to expand reach. Channel partnerships can support training, certification, and ongoing service while co marketing with PBM specialists can raise adoption across the US and Europe.